OpGen, an early-stage Madison biotechnology company, has received $5 million in venture capital. Investors in the second-round funding include the Wisconsin Alumni Research Foundation.
Office of Strategic Communication
OpGen, an early-stage Madison biotechnology company, has received $5 million in venture capital. Investors in the second-round funding include the Wisconsin Alumni Research Foundation.